Mutations in the PARK2 gene encoding parkin, an E3 ubiquitin ligase, are associated with autosomal recessive early-onset Parkinson's disease (PD). While parkin has been implicated in the regulation of mitophagy and proteasomal degradation, the precise mechanism leading to neurodegeneration in both sporadic and familial PD upon parkin loss-of-function mutations remains unknown. Cultures of isogenic induced pluripotent stem cell (iPSC) lines with and without PARK2 knockout (KO) enable mechanistic studies of the effect of parkin deficiency in human dopaminergic neurons. In the present study, we used such cells to investigate the impact of PARK2 KO on the lysosomal compartment combining different approaches, such as mass spectrometry-based proteomics, electron microscopy (TEM) analysis and functional assays. We discovered a clear link between parkin deficiency and lysosomal alterations. PARK2 KO neurons exhibited a perturbed lysosomal morphology, displaying significantly enlarged and electron-lucent lysosomes as well as an increased total lysosomal content, which was exacerbated by mitochondrial stress. In addition, we found perturbed autophagic flux and decreased lysosomal enzyme activity suggesting an impairment of the autophagylysosomal pathway in parkin-deficient cells. Interestingly, activity of the GBA-encoded enzyme, b-glucocerebrosidase, was significantly increased suggesting the existence of a compensatory mechanism. In conclusion, our data provide a unique characterization of the morphology, content, and function of lysosomes in PARK2 KO neurons, thus revealing a new important connection between mitochondrial dysfunction and lysosomal dysregulation in PD pathogenesis.
Introduction
Parkinson's disease (PD) is a progressive neurodegenerative disorder affecting 1-2% of the population. Although the majority of PD patients develop late-onset sporadic disease, a subpopulation of patients develops early-onset or familial PD forms associated with various genetic mutations. Studies of the effects of these mutations can provide valuable insights into the molecular pathways and mechanisms that lead to degeneration of dopaminergic neurons in PD (1) (2) (3) (4) .
Mutations in the PARK2 gene, encoding the protein parkin, have been identified as the most common cause of autosomal recessive early-onset PD and have underlined the importance of mitochondrial dysfunction in PD pathogenesis (5) (6) (7) . Parkin is a multifunctional E3 ubiquitin ligase involved in several cellular processes. Parkinmediated ubiquitination of mitochondrial proteins (8) (9) (10) (11) triggers clearance of impaired mitochondria through the autophagy-lysosome pathway (ALP) (12) . Lysosomes are organelles specialized for the degradation of macromolecules derived from the extracellular space through endocytosis or phagocytosis, or from the cytoplasm through autophagy. In recent years, the importance of lysosomes in pathology has been indicated by a rapidly growing number of human disorders linked to defects in lysosomal function including PD (13, 14) in which the accumulation of non-degraded and misfolded proteins occurs. Mutations in the GBA gene, coding for the lysosomal glycohydrolase b-glucocerebrosidase (GCase), cause Gaucher's disease and several studies have reported GBA mutations as the numerically greatest genetic risk factor for PD (15) (16) (17) .
A number of studies point to an interplay between mitochondrial homeostasis and proper lysosomal function. Diseases caused by mutations of ALP proteins often exhibit mitochondrial defects as well (18) (19) (20) . Of relevance for PD, loss of GCase activity leads to mitochondrial dysfunction indicating that impaired lysosomal function negatively impacts mitochondria (17) . Supporting this, autophagy enhancing drugs such as rapamycin has neuroprotective effects against the mitochondrial complex I inhibitor rotenone in cellular models of PD (21) . Interestingly, mitochondrial dysfunction induced by rotenone treatment alters the expression of lysosomal genes, which perhaps is explained by the fact that mitophagy induction through nuclear translocation of transcription factors regulates mitochondrial and lysosomal biogenesis (22, 23) . Recent studies have documented mitochondria-lysosome membrane contact sites, which enable bidirectional regulation of mitochondrial and lysosomal dynamics, and have demonstrated how mitochondrial impairment supresses autophagic flux, overall suggesting a complex mutual relationship between these two cellular compartments (24) (25) (26) (27) (28) .
However, the exact relationship between mitochondrial-and lysosomal function in PD is not well defined (23, 27, 28) and elucidation of a potential link between them and its role in the pathogenic process is still required. By studying the lysosomal compartment and function in the context of parkin deficiency, we sought to address whether chronic mitochondrial dysfunction causes lysosomal impairment, contributing to PD pathogenesis. For this purpose, we studied isogenic iPSC-derived neuronal cultures with and without PARK2 mutation, which we have recently demonstrated lead to several mitochondrial defects (29) . Parkin deficiency resulted in a number of perturbations including altered lysosomal content, morphology and function as well as impaired autophagic flux, indicating a connection between parkin deficiency and lysosomal disturbances.
Results

Identical differentiation potentials of PARK2 KO iPSCs and control lines
To study the disease mechanism underlining PARK2-mediated PD, we analyzed two isogenic iPSC lines created from a healthy control iPSC line, where KO of the PARK2 gene was created by zinc finger nuclease gene editing technology (30) . Detailed cell line information is reported in our recent study (29) .
PARK2 KO and isogenic control iPSC-derived neuronal stem cells (NSCs) were differentiated simultaneously to assess the efficiency of midbrain dopaminergic neuron yield ( Fig. 1A ). Fig. 1B shows representative immunofluorescence pictures of cultures differentiated for 25 days, revealing a large percentage of MAP2+ mature neurons with distinct cell bodies and long branched processes forming highly interconnected networks. No apparent difference in the percentage of mature neurons was observed (control: 69.8 ± 1.0%, PARK2: 68.4 ± 0.9%) (Fig. 1C) . The differentiated cells were also positive for NeuN and synaptophysin markers, which confirmed their maturity (Bogetofte et al., submitted) . Many of the generated neurons were found to co-localize with the dopaminergic marker tyrosine hydroxylase (TH), which is the rate-limiting enzyme in the production of dopamine. No apparent difference in the amount of TH+ dopaminergic neurons was observed between cell lines (control: 25.25 ± 1.0%, PARK2:
24.6 ± 1.1%) ( Fig. 1D) . Moreover, the presence of GABAergic+ neurons and a small population of GFAP+ astrocytes was also found in the cultures (Bogetofte et al., submitted) . Western blot analysis showed similar amounts of MAP2 and TH protein expression between control and PARK2 KO cell lines, confirming the immunofluorescence staining (Figs. 1E, F). qRT-PCR analysis detected the presence of midbrain dopaminergic specific markers (EN1, NURR1, GIRK2) in the differentiated neuronal cultures (Fig. 1G ). Both lines showed comparable expression levels with no significant differences. These data show that PARK2 KO does not affect the neuronal differentiation potential of the iPSC-derived NSCs, as both the PARK2 KO and isogenic control lines were equally efficient in generating midbrain dopaminergic neurons.
Proteomic changes and increased lysosomal content in PARK2 KO neurons
As earlier reported we have subjected PARK2 KO and isogenic control neuronal cultures to a mass spectrometry-based proteomic analysis, which enabled the identification and quantification of a large number of proteins (29) . Based on this recently published dataset (29) we detected significant changes in levels of 22 lysosomal proteins in PARK2 KO neurons ( Table 1) . A number of these proteins were of importance for vesicle-mediated protein trafficking through the endosomal-lysosomal system and for the ALP pathway ( Table 1) . This indicated that lysosomal perturbations were indeed present in the PARK2 KO neurons and led us to examine the overall lysosomal content of PARK2 KO neurons. Interestingly, levels of both lysosomal associated membrane protein 1 and 2a (LAMP1/2a), which are often used as general markers for lysosomes, were significantly elevated as quantified by Western blotting ( Figs. 2A, B ), pointing to an overall increased lysosomal content in the PARK2 KO neurons.
TEM evidences for lysosomal abnormalities in PARK2 KO neurons
To further investigate the lysosomal perturbations suggested by the proteomic analysis we applied transmission electron microscopy (TEM) analysis, which revealed several ultrastructural disturbances within lysosome-like structures. Lysosomes were identified as electron-dense small spherical organelles, enclosed by a single membrane, with a size of about 0.5-1.0 µm in diameter (31) . Ultrastructural assessment of the PARK2 KO and healthy control neurons detected clear differences in lysosomal morphology between the two cell lines. Lysosomes in neurons with PARK2 KO were more heterogeneous and characterized by the presence of large translucent areas, whereas lysosomes from healthy control neurons more uniformly displayed an electron-dense inner compartment ( Fig. 2C) . Quantitative analysis of the number of lysosomes confirmed a significant accumulation of lysosomes in PARK2 KO neurons compared to healthy isogenic controls (70% increase, p < 0.01) ( Fig. 2D) . The area of the individual lysosomes was increased for PARK2 KO neurons by approximately 40% (p < 0.01) compared to controls ( Fig. 2E) . This verified the presence of enlarged lysosomal vacuoles observed for PARK2 KO neurons. In addition, the mean gray value (a measure of lysosomal electron density) was significantly reduced for PARK2 KO neurons (20% decrease, p < 0.05) ( Fig. 2F ). This led us to categorize lysosomes into two groups: electron-lucent (lighter) and electron-dense (darker), and we found a significantly greater amount of electron-lucent lysosomes in the PARK2 KO neurons compared to controls (37.5% vs. 24 .8%, respectively, p < 0.01) ( Fig. 2G) . Overall, TEM analysis revealed significant morphological changes in lysosomes between PARK2 KO neurons and isogenic control neurons. Lysosomal vacuoles appeared to be more abundant, larger and more electronlucent (lighter) in PARK2 KO neurons than in controls.
Altered lysosomal abundance in mature PARK2 KO neurons
In order to investigate the time course of the lysosomal accumulation during the differentiation of PARK2 KO neurons, we investigated the abundance of lysosomes at different time points by immunofluorescence staining using the lysosomal marker LAMP1 (Figs. 3A-E). We did not observe significant differences in the pattern of 
Increased lysosomal abundance after CCCP treatment
To investigate whether the accumulation of lysosomes observed in PARK2 KO neurons at day 25 was a direct consequence of mitochondrial impairment we studied the lysosomal response to mitochondrial stress caused by carbonyl cyanide m-chlorophenyl hydrazine (CCCP), a proton ionophore that collapses the proton electrochemical gradient across membranes, thus acting as a potent uncoupler of respiratory chain function and oxidative phosphorylation (32) . After 48 hours of CCCP (10 µM) exposure, the area of lysosomes in control cells had increased to a level similar to that of PARK2 KO untreated neurons (41.8 vs. 40.15 arbitrary units, respectively, p = 0.98), strongly indicating that mitochondrial function impairment leads to lysosomal accumulation. Interestingly, CCCP treatment of PARK2 KO neurons resulted in further enhancement of LAMP1 staining (Figs. 3G, H) , consistent with the hypothesized mitochondrial dysfunction present in these cells and indicating that this is a general consequence of mitochondrial dysfunction. Taken together, our data show that exposure to mitochondrial stressors, like CCCP, results in elevated lysosomal area in both PARK2 KO and healthy neurons, which provides further evidence of a causative link between mitochondrial dysfunction and lysosomal alterations.
Perturbed lysosomal function and autophagic flux in PARK2 KO neurons
To determine whether the alterations in lysosome protein levels and overall organelle structure may impact lysosomal function, we performed several functional assays. The In order to establish if the alterations detected in the lysosomal function also affected the autophagic process, as alluded to by the proteomic analysis ( Table 1) , we analyzed through Western blotting the expression of microtubule-associated proteins 1A/1B light chain 3 (gene MAP1LC3A in Table 1 ), a known marker of autophagy (33) . The total amount of LC3 protein was significantly decreased in PARK2 KO neurons at baseline confirming the results from the proteomic analysis (Table 1, Figs. 4H, 4I). LC3-II protein turnover was measured as the ratio between protein levels of LC3-II and LC3-I in the presence and absence of bafilomycin A1, which inhibits lysosomal acidification and fusion of autophagosomes with the lysosome. At baseline the PARK2 KO neurons compared to control had a significantly increased LC3-II/LC3-I ratio, which however was unaffected by bafilomycin A1 treatment. In contrast the control neurons showed a significant increase in the LC3-II/LC3-I ratio upon bafilomycin A1 treatment (Figs. 4H, 4J ). This indicates that autophagy induction is occurring, but that in the PARK2 KO neurons the autophagic process is stalled due to lysosomal impairment. Overall, the PARK2 KO neurons showed a significantly decreased autophagy process compared to healthy control neurons (approximately 30% decrease, p < 0.01) ( Fig. 4K) . In conclusion, these data overall provide strong and consistent evidence of a perturbed lysosomal activity and compromised autophagic flux in the PARK2 KO neurons.
Discussion
The importance of parkin dysfunction in familial and sporadic PD is well established, but the exact mechanism and pathways are not well understood (6, 33) . Parkin was associated with mitochondrial function for the first time through studies in Drosophila M. (34) . However, today we know that the parkin protein has multiple roles and that it is crucial for the proper function of not only mitochondria but also lysosomes (23, 34) .
A common feature shared by these two organelles is that mitochondrial defects and lysosomal function impairment can lead to neurological pathologies, suggesting functional connections between these two organelles (35, 36) .
In our recent report we demonstrated prominent mitochondrial-related defects and the mitochondrial proteome perturbations (29) in response to parkin deficiency. Therefore, to explore the reciprocal relationship between mitochondrial and lysosomal pathways in PD, in the present study we investigated the impact of parkin dysfunction on lysosome structure and function by applying human iPSC-derived neurons with PARK2 mutations and isogenic healthy control. We identified striking differences in lysosomal abundance, morphology, content and activity in the PARK2 KO neurons. Endolysosomal alterations have been documented in other parkin dysfunction models (37, 38) . However, to our knowledge, this is the first experimental evidence obtained from human PARK2 KO iPSC-derived neurons.
One of the consequences of mitochondrial deficits caused by parkin dysfunction in this cellular model of PD was an increased lysosomal number and size. This altered phenotype appeared at differentiation day 25, when the cells also exhibit aberrant mitochondria, indicating increased vulnerability of mature neurons (29) . Similar lysosomal alterations to those observed in our study were detected in mitochondrial mutants exhibiting disrupted mitochondrial fission-fusion processes and cristae structure and mitochondrial impairment (27, (39) (40) (41) . A recent study in mice and cellular models of mitochondrial dysfunction reported a ROS-dependent increase in numbers of lysosomal vacuoles, suggesting a possible mechanism (27) . Mitochondrial activity is required to maintain proper lysosomal structure and function, as demonstrated by studies applying chemical inhibition of the electron transport chain, as well as in in vitro and in vivo genetic models of mitochondrial dysfunction. Specifically, disruption of mitochondrial function causes the accumulation of enlarged endo-lysosomal structures (27, 39, 42, 43) .
Our study supports these observations, as lysosomal numbers were increased following uncoupling of mitochondrial function by CCCP treatment in both neuronal populations.
CCCP-treated control neurons contained almost equal numbers of lysosomes as PARK2
KO untreated neurons, pointing to an association between lysosomal accumulation and mitochondrial membrane depolarization caused by CCCP. In line with this, an increase in lysosomal number was found in HeLa cells following treatment with the electrogenic ionophore agents CCCP and valinomycin (44) . Recently, acute CCCP treatment was found to promote lysosomal biogenesis through activation of transcription factor EB (TFEB) (23, 45) . TFEB regulates both mitochondrial and lysosomal biogenesis and is translocated to the nucleus upon starvation, mitophagy induction and when lysosomal function is impaired (46-48). Whether TFEB translocation/activation is responsible for the increased lysosomal content in PARK2 KO neurons remains to be examined.
Another contributing factor to the increased lysosomal content in PARK2 KO neurons could be an impaired lysosomal degradation capacity and the build-up of undegraded cargo, as reported in iPSC-derived dopaminergic neurons from GBA patients (47, 49) .
Applying TEM we detected an increased number of large electron-lucent lysosomes in PARK2 KO neurons. These less electron-dense lysosomes might represent lysosomes in which digestion of the contents is perturbed, as the normally dark lumen is a result of enzymes actively degrading the material in acidic lysosomal interior (31) . Similar observations of enlarged and electron-lucent lysosomal vacuoles are described in lysosomal storage disorders (50) (51) (52) . Supporting this notion, the overall lysosomal enzyme activity was significantly decreased in the PARK2 KO neurons. A recent study on cellular models of mitochondrial dysfunction induced by chemical stressors or deletion of mitochondrial proteins including PINK1, also documented impaired lysosomal enzyme activity. These changes were dependent on ROS levels, as antioxidant treatment could revert the observed phenotypes (27) . Given that the PARK2 KO neurons have decreased levels of antioxidant defense enzymes (29), a similar mechanism could be relevant in the observations made in the present study.
The impaired lysosomal enzyme activity found here is a likely cause of the compromised autophagic flux in the PARK2 KO neurons. However, as indicated by the proteomic data perturbations in levels of proteins involved in the autophagic process including LC3, which was significantly decreased, were also present. Decreased autophagic flux has similarly been documented in a recent study performed on PARK2-PD fibroblasts as well as in iPSC-derived neurons from GBA-and sporadic PD patients (47, 53, 54) .
Interestingly, the GCase activity was significantly increased in the PARK2 KO neurons whereas activity of b-Gal and overall lysosome enzymatic activity were reduced. This points to the activation of a compensatory mechanisms to increase GCase activity, as the total protein level of GCase was unchanged. A direct interaction between parkin and GCase could explain such link, as parkin can directly interact with and mediate degradation of mutant GCase (55). However, this was not the case for wildtype GCase and further studies are needed in order to address the interplay between GCase activity and parkin disfunction.
In conclusion, our results indicate that the loss of PARK2 causes several lysosomal perturbations affecting their abundance, morphology, content and activity. Taken together with our previous data, these findings contribute to causally link two major pathological features of PD, namely mitochondrial defects and lysosomal dysregulation, supporting the idea of a direct pathogenic positive feedback between the two organelles. Future efforts must be focused on the identification of the molecular mechanistic pathways connecting mitochondrial and lysosomal perturbations with the aim of developing therapeutic approaches for PD. 
Materials and Methods
CCCP (cyanide m-chlorophenylhydrazone) and BAF (bafilomycinA1) treatments
Lysis, reduction and enzymatic digestion
Samples were sonicated for two times ten seconds at 50% amplitude on ice and 
Hydrophobic interaction liquid chromatography (HILIC) and high pH fractionation
Mono-phosphorylated and non-modified peptides were fractionated to reduce sample complexity using HILIC. To increase the coverage, high pH fractionation was also performed using approximately 50 µg peptide of the non-modified peptide sample.
Briefly, the sample was dissolved in 1% ammonium hydroxide (NH3, Sigma), pH 11, and loaded on a R2/R3 column equilibrated with 0.1% NH3. The peptides were eluted in a stepwise fashion using a gradient of 5%-60% ACN/0.1% NH3. All fractions were dried by vacuum centrifugation.
Reversed-phase nano LC-ESI-MS/MS
The samples were resuspended in 0.1% formic acid (FA) and loaded onto a two-column EASY-nLC system (Thermo Scientific). The pre-column was a 3 cm long fused silica capillary (100 µM inner diameter) with a fritted end and in-house packed with ReproSil Fragmentation was performed at high resolution (60,000 FWHM) for a target of 1x10 5 and a maximum injection time of 60ms using an isolation window of 1.2 m/z and a dynamic exclusion. All raw data were viewed in Thermo Xcalibur v3.0.
Mass spectrometry data analysis
The raw data were processes using Proteome Discoverer (v2.1, ThermoFisher) and were considered for further analysis. Only proteins with more than one unique peptide were considered for further analysis in the non-modified group.
Sample preparation for transmission electron microscopy (TEM)
The TEM sample preparation procedure included five major steps: fixation, dehydration, infiltration and embedding, sectioning, and contrasting. Cells were seeded on 13 mm Thermanox plastic coverslips (Nunc) with a density of 80.000 cells/cm 2 . At day 25 of differentiation cell were primarily fixed in 3% gluteraldehyde (Merck) in 0.1 M Natrium phosphate buffer with pH 7.2 at 4°C for 1h and stored in a 0.1 M Naphosphate buffer at 4°C until further analysis. When ready, the cells were embedded in 4% agar at 45°C (Sigma) under the stereomicroscope and cut into 1-2 mm 3 blocks, which were then washed with 0.1 Na-phosphate buffer, followed by a post-fixation in 1% osmium tetroxide (EMS) in 0.1 Na-phosphate buffer (pH 7.2) for 1h at RT. Cells were washed in MilliQ water, followed by a stepwise dehydration in a series of ascending ethanol concentrations ranging from 50% EtOH to 99% EtOH). Then propylene oxide (Merck) was used as an intermediate allowing for infiltration with Epon (812 Resin, TAAB). The following day, the agar blocks were placed in flat molds in pure Epon, which was cured at 60°C for 24h. Approximately 8 semi-thin sections (2 μm) from one block were cut on an ultramicrotome with glass knife (Leica, Reichert Ultracut UTC). These were stained with 1% toluidine blue in 1% Borax and evaluated by light microscopy to locate areas with adequate number of cells for further processing.
Ultra-thin sections (70 nm) were cut on the ultramicrotome with a diamond knife (Jumdi, 2 mm), and the ultra-thin sections were collected onto TEM copper grids (Gilder), and then stained with 2% uranyl acetate (Polyscience) and lead citrate (Reynolds 1963). The samples were then evaluated and the image database collected using a Philips CM100 transmission electron microscope equipped with a Morada digital camera equipment and iTEM software system.
Measurements of lysosomal numbers on TEM images
Six TEM grids from each line were used for analysis, and at low magnification 10 spots were randomly chosen. Images of each spot were captured using high magnification (19.000X). To estimate lysosomal number, all lysosomes were counted on each micrograph. For further morphometric analysis individual organelles were selected and processed manually using the different selection tools in ImageJ software. Tween-20 in 0.05M TBS for 5 min at RT, followed by chemiluminescence development (ECL kit, ThermoFisher Scientific) and visualization using the ChemiDoc MP imaging system (BioRad). As loading control, all blots were subsequently incubated with α-actin antibody (mouse anti-α-actin, #MAB1501, Chemicon/Millipore; 1:6000) ON at 4°C and developed as described above. Densitometric analyses of band intensities were quantified using Image Lab software (BioRad) and protein expression levels were normalized to α-actin. 
Western blotting
Immunofluorescence staining
Total Lysosomal Intracellular Activity Assay
Measurement of the total lysosomal intracellular activity was performed using Lysosomal Intracellular Activity Assay Kit (Cell-Based) (BioVision) according to manufacturer's protocol. Briefly, cells were plated on 13 mm glass coverslips in a 24well culture plate (40.000 cells/cm 2 ). Prior to the analysis the cells were incubated for 8h in medium supplemented with 10% FBS at 37°C. Then the media was removed and replaced with fresh aliquots supplemented with 0.5% FBS. 15 µl of Self-Quenched Substrate was added per 1 ml of media into each well and the plate incubated for 1h at 37°C. 10 min before the end of incubation 1:1000 Hoechst solution (Sigma) was added to each well to stain nuclei. After incubation the cells were analyzed under fluorescence microscope with 488 nm excitation filter to visualize the fluorescence of released Self-Quenched Substrate, which proportional to the total lysosomal intracellular activity.
Fluorescence images were acquired on a FluoView FV1000MPE -Multiphoton Laser
Confocal Microscope (Olympus) 60X magnification, in a blinded manner on 5 randomly chosen confocal fields per coverslip from independent experiments. Analysis was performed automatically in ImageJ software by converting images to binary format and analyzing particles. Total area of the staining was normalized to total cell numbers as quantified by Hoechst+ nuclei analysis in ImageJ software.
Beta Galactosidase (β-Gal) Assay
Measurement of β-Gal activity was performed using Fluorometric Beta Galactosidase Activity Assay Kit (BioVision) according to manufacturer's protocol. Briefly, cells were plated in a 6-well plate (60.000 cells/cm 2 ) and homogenized with on ice with 100 µl ice cold β-Gal Assay Buffer and kept on ice for 10 min. Cell lysates were transferred to eppendorf tubes and centrifuged at 10.000 g, 4°C for 5 min, and subsequently 
Autophagic Flux
To examine the autophagic flux, we determined if LC3 is degraded in a lysosomaldependent manner by using bafilomycin A1, an inhibitor of lysosomal acidification but also, independently of its effect on lysosomal pH, of fusion between autophagosomes and lysosomes. To this purpose, differentiated neurons were incubated with DMSO (untreated) or with medium containing bafilomycin A1 (10 nM for 6 h). Western blot analysis was performed on cell lysates using antibodies against LC3 (Cell Signaling) and α-actin (Abcam). The ratio between LC3-II and LC3-I was calculated and normalized to α-actin, through densitometric analysis using ImageJ software, and the autophagic flux was calculated as the ratio of LC3-II of cells treated with bafilomycin A1 and untreated cells.
Statistical analysis
Statistical analysis was performed in GraphPad Prism 7.0 software using two-tailed unpaired Student's t-test and one-way ANOVA with Tukey's Multiple Comparison Test where appropriate. Data were considered statistically significant at p < 0.05 (*), p < 0.01 (**) and p < 0.001 (***). Data are presented as mean ± standard error of the mean (SEM). 
Figure legends
